DailyDoctor Archive Specialties Get app
Back to the 16 October 2026 edition

Clinical update · 01 of 05

CRP-triggered CT cut ileostomy formation to 22% after laparoscopic low anterior resection

Consider auditing local leak and stoma rates and discussing a CRP and CT-guided selective approach, but do not drop routine diversion for high-risk anastomoses on one small trial.

Design
Randomised controlled trial, 1:1, retrospectively registered
Population
200 patients with stage II or III middle or lower third rectal cancer undergoing laparoscopic low anterior resection
Primary outcome
Stoma-free status through 12 months
Effect
Ileostomy 22.0% vs 100.0% (p < 0.001); leak 0% vs 1.0%; complications 31.0% vs 32.0%

Diverting ileostomy is routine after low anterior resection for rectal cancer even though few patients develop a true anastomotic leak. This randomised trial assigned 200 patients with stage II or III middle or lower third rectal cancer, all undergoing laparoscopic resection, to routine ileostomy or a selective strategy. In the selective arm CRP was measured daily from day 1, and a day 3 value of 114 mg/L or a rise of more than 15 mg/L a day triggered contrast CT. An ileostomy was formed only if the CT was suspicious for leak.

Ileostomy formation was 22.0% in the selective arm and 100% in the routine arm. Confirmed leakage was 0% versus 1.0% and overall complications were 31.0% versus 32.0%. Stoma-related complications were 3.0% versus 30.0%, and patient-reported global health and physical and emotional functioning scores were better in the selective arm.

Leaks were so rare in both arms that the trial cannot show the selective approach is as safe for leak consequences; it was also retrospectively registered, and the protocol includes daily CRP and ready CT access. It supports further study and local audit more than a switch away from routine diversion.

  • Selective diversion used daily CRP from day 1, with CT triggered at CRP 114 mg/L on day 3 or a rise over 15 mg/L a day.
  • Ileostomy was formed in 22% of the selective arm against all patients in the routine arm.
  • Leak was 0% versus 1.0%, too few events to show equal safety.
  • The approach assumes daily bloods, rapid CT and surgeons able to return to theatre for a stoma.
  • Consider discussing it in your unit's rectal cancer meeting; do not adopt it on this trial alone.

Why it matters

It challenges the assumption that every low anastomosis needs a stoma to protect it.

Don't overread it

Retrospective trial registration and very few leaks mean the safety of omitting diversion is not established.

The statistics, in plain English

Zero leaks in one arm and one in the other means the study had almost no information on leak itself, so 'no difference' here means 'too few events to tell', not 'equally safe'. The large drop in stomas is a robust finding because the control arm was 100% by design.

Read the rest in the app

You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this finding is waiting in it.

QR code to install Daily Doctor
Get Daily Doctor — free

Scan to keep reading on your phone. No account needed to start.

colorectalsurgcompmishpbuppergi

Tomorrow morning, before your first patient

One edition a day for general surgery, written by the desk, every claim tied to its paper. Six minutes.

Get the app — free
Daily Doctor All 27 specialties, every morning. Free.
Get the app